Neuralink Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 100
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $51M
Latest Deal Amount
  • Investors
  • 5

Neuralink General Information

Description

Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is designed to treat and diagnose neurological conditions in humans and conceivably augment human cognitive powers, enabling doctors to treat serious brain diseases in the short-term.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 3180 18th Street
  • Suite 200
  • San Francisco, CA 94110
  • United States
+1 (650) 000-0000

Neuralink Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuralink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 28-Jun-2019 $51M 00000 00000 Completed Startup
1. Early Stage VC (Series A) 24-Aug-2017 00000 00000 00000 Completed Startup
To view Neuralink’s complete valuation and funding history, request access »

Neuralink Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B-1 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 107,000,000 $0.001000 $0.05 $1 $1 1x $1 78.45%
To view Neuralink’s complete cap table history, request access »

Neuralink Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface is d
Diagnostic Equipment
San Francisco, CA
100 As of 2021
00000
0000 0000-00-00
00000000000 00000

00000000

r in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
0000000000 0000000 (0000000000)
Santa Clara, CA
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuralink Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000000 Venture Capital-Backed Santa Clara, CA 00 000.00 000000000 - 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Neuralink Executive Team (10)

Name Title Board Seat Contact Info
Max Hodak Co-Founder & President
Dongjin Seo Vice President of Implant & Founding Member
Paul Merolla Ph.D Co-Founder
Shivon Zilis Project Director, Office of the CEO
Jared Birchall Chief Executive Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Neuralink Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuralink Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Craft Ventures Venture Capital Minority 000 0000 000000 0
DFJ Growth Venture Capital Minority 000 0000 000000 0
Dreamers VC Venture Capital Minority 000 0000 000000 0
Future Ventures (San Francisco) Venture Capital Minority 000 0000 000000 0
Valor Equity Partners Growth/Expansion Minority 000 0000 000000 0
To view Neuralink’s complete investors history, request access »